JERUSALEM--(BUSINESS WIRE)--Oct. 12, 2015-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the exclusive launch of the generic equivalent to Avodart® (dutasteride) capsules, 0.5 mg, ...
Teva Pharmaceutical Industries Ltd, a leading global pharmaceutical company, announced the exclusive launch of the generic equivalent to Avodart (dutasteride) capsules, 0.5 mg, in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results